Paradeep Phosphates (PARADEEP) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
19 Dec, 2025Executive summary
Q3 FY25 saw robust production and sales growth, with production up 25% and sales up 47% year-on-year; nine-month production rose 4% and sales 13% year-on-year.
Total income for Q3 FY25 was ₹41,049 million, up 58% year-on-year, and ₹103,262 million for 9M FY25, up 11% year-on-year.
Focus remains on value-added NPK fertilizers, with seven unique NPK grades and DAP produced to meet diverse farmer needs; strong traction for new products like Triple Super Phosphate and biogenic nano-fertilizers, with nano-fertilizer sales surpassing 1.4 million bottles in nine months.
Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024.
Financial highlights
Q3 FY25 income from operations was INR 4,105 crore, up 58% year-on-year; EBITDA reached INR 372 crore with a 9% margin.
Q3 PAT was INR 159 crore, up 47% year-on-year, with a PAT margin of 4%; nine-month PAT was INR 392 crore (3.8% margin).
Basic EPS for Q3: ₹1.95, up 45.5% YoY; nine-month EPS: ₹4.81.
Gross debt stood at INR 4,000 crore, with net debt at INR 2,600 crore after cash adjustment.
Received INR 1,750 crore in subsidy for the quarter, with INR 1,700 crore pending.
Outlook and guidance
Expecting to deliver a positive FY 2025, with continued focus on optimizing fertilizer mix, managing raw material price fluctuations, and operational excellence.
Full benefit of backward integration projects, especially sulfuric acid expansion, expected in the second half of FY 2026.
Sales volume for FY 2025 projected to approach 2.9–3 million tons, with similar or higher levels expected in FY 2026 as integration benefits materialize.
Board approved a composite scheme of arrangement for the merger of Mangalore Chemicals & Fertilizers Limited with the company; accounting effect to be given upon receipt of approvals.
Latest events from Paradeep Phosphates
- Revenue up 36% YoY, EBITDA up 25%, with strong DAP sales and MCFL merger boosting growth.PARADEEP
Q1 26/2731 Jul 2026 - Strong growth in revenue, profit, and volumes, boosted by MCFL merger and expansion projects.PARADEEP
Q3 25/268 Jul 2026 - Q1 FY26 revenue up 58% YoY, EBITDA nearly doubled, and MCFL merger nears completion.PARADEEP
Q1 25/268 Jul 2026 - Net profit up 134.7% YoY in H1 FY26, driven by MCFL merger and major capacity expansion.PARADEEP
Q2 25/268 Jul 2026 - Strong revenue and profit growth, major merger, and expanded NPK and value-added product capacity.PARADEEP
Q4 25/2619 May 2026 - Profitability improved despite lower Q1 volumes; new launches and merger progress support outlook.PARADEEP
Q1 24/259 Feb 2026 - Record profit and sales growth, strong cash flow, and capacity expansion ahead.PARADEEP
Q4 24/2519 Dec 2025 - Q2 FY25 profit soared 155% YoY, with major phosphoric acid expansion approved.PARADEEP
Q2 24/2519 Dec 2025